Navigate With Confidence

Bionavigen is a biopharmaceutical navigation company specializing in consulting for the discovery, preclinical development, translational, and regulatory sciences as well as early development of new drugs through smart acquisition.

Drug Hunting

Discovery

CMC

ADC Drug Development

Preclinical Development

Translational Sciences

Immuno-Oncology

Clinical Development

Regulatory Sciences

Why Bionavigen?

Bionavigen offers real world drug development experience-based consulting services for biologics including:

  • Antibodies
  • Peptides
  • Recombinant proteins
  • Bispecifics
  • Antibody drug conjugates (ADC)
  • Oncolytic virus (gene editing and gene delivery)
  • Viral
  • Cell
  • Gene therapy
  • Small molecule pharmaceuticals
  • Therapeutic peptides
  • Medical devices

Bionavigen Advantage:

  • A team of virtual full drug developers (preclinical, clinical and regulatory experts)
  • Actively engaged in acquisition of clinical stage biologics and small molecule drugs from pharmaceutical companies supported by funds from VC investment firms
  • Support from early VC funding to early proof-of-concept clinical trials

Bionavigen Drug Hunting Services:

  • Navigation of the current and future pipeline of the top ten biopharmaceutical companies
  • Smart due diligence of potential out-licensing candidates using the latest scientific knowledge and soft intelligence
  • Special emphasis on promising drug candidates in new disease indications or through new innovative combinations
  • Investor backed drug acquisition and development through proof-of-concept
30
Years of Experience
10
Marketed Biopharmaceuticals
100+
INDs
15
BLAs-NDAs

Clients

Partners